Context Therapeutics (CNTX) Stock Chart & Stock Price History $1.50 0.00 (0.00%) (As of 12/6/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Context Therapeutics Stock Price Performance 5 Day Performance-0.66%1 Month Performance-23.08%3 Month Performance-35.34%6 Month Performance-12.28%Year-To-Date Performance+32.74%1 Year Performance+72.41% Receive CNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Do you know about this? (Ad)In September of 2023, U.S. officials and a handful of the most powerful tech elites in the world … Held closed door meetings about Artificial Intelligence. The so-called "AI safety and regulation talks" …Click here to learn more. CNTX Stock Chart for Sunday, December, 8, 2024 CNTX Chart by TradingView Context Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/06/2024$1.50$1.50$1.53$1.43188,295 shs$112.50 million12/05/2024$1.51$1.50-0.66%$1.52$1.48166,157 shs$112.50 million12/04/2024$1.51$1.51$1.57$1.4848,747 shs$113.25 million12/03/2024$1.56$1.51-3.21%$1.56$1.49156,727 shs$113.25 million12/02/2024$1.52$1.56+2.63%$1.65$1.4890,610 shs$117.00 million11/29/2024$1.50$1.52+1.33%$1.55$1.5045,803 shs$114 million Get the Latest News and Ratings for CNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/28/2024$1.50$1.50$1.55$1.4770,644 shs$112.50 million11/27/2024$1.47$1.50+2.04%$1.55$1.4770,644 shs$112.50 million11/26/2024$1.46$1.47+0.68%$1.53$1.42161,402 shs$110.25 million11/25/2024$1.39$1.46+5.04%$1.55$1.39331,550 shs$109.50 million11/22/2024$1.50$1.39-7.33%$1.43$1.27790,017 shs$104.25 million11/21/2024$1.63$1.50-7.98%$1.58$1.32564,764 shs$112.50 million11/20/2024$1.65$1.63-1.21%$1.67$1.51129,005 shs$122.25 million11/19/2024$1.68$1.65-1.79%$1.74$1.61151,075 shs$123.75 million11/18/2024$1.84$1.68-8.70%$1.84$1.56311,441 shs$126 million11/15/2024$1.90$1.84-3.16%$1.89$1.78133,350 shs$138 million11/14/2024$1.97$1.90-3.55%$1.97$1.84142,776 shs$142.50 million11/13/2024$2.05$1.97-3.90%$2.10$1.9680,553 shs$147.75 million11/12/2024$2.04$2.05+0.49%$2.10$1.94217,134 shs$153.75 million11/11/2024$1.95$2.04+4.62%$2.07$1.93128,122 shs$153.00 million11/08/2024$2.09$1.95-6.70%$2.09$1.90338,993 shs$146.25 million11/07/2024$2.22$2.09-5.86%$2.25$2.07116,458 shs$156.75 million Related Companies SLRN Stock Price Chart KRRO Stock Price Chart AQST Stock Price Chart AKBA Stock Price Chart AURA Stock Price Chart FHTX Stock Price Chart CGC Stock Price Chart KALV Stock Price Chart GHRS Stock Price Chart TNGX Stock Price Chart Receive CNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNTX) was last updated on 12/8/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredUrgent warning about your moneyThe stock market is booming … And Bitcoin just hiked through the roof. But don't get fooled by the "good...Weiss Ratings | SponsoredElon declares war on company he co-founded!?Elon Musk is leading humanity into the new era of AI. He’s just received a fresh $6 billion in funding for ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Context Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Context Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
